Thousands more people with advanced bowel cancer to benefit as NICE approves bevacizumab biosimilars
More than 7,000 people in England will now be able to access to a life-extending treatment for advanced bowel cancer.
We produce useful and usable guidance for the NHS and wider health and care system.
Our recommendations help practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer.
Latest from NICE
NICE announces Professor Jonathan Benger as new Chief Executive
NICE Chairman, Sharmila Nebhrajani, today announced Professor Jonathan Benger CBE as incoming chief executive, with effect from Friday 19 December 2025 taking over from Dr Samantha Roberts.
Seven digital platforms supporting at home cardiac rehab given conditional recommendations
People with heart disease will be able to do their recovery sessions from home rather than travelling for rehabilitation appointments after our independent committee conditionally recommended 7 digital platforms for use in the NHS.
Changes to NICE’s cost-effectiveness thresholds confirmed
The government has today (1 December 2025) announced that it will increase the thresholds NICE uses in evaluations of new medicines to decide which are cost-effective for use in the NHS.
Implementation and planning
Best practice resources for practitioners and commissioners.
Helping you define, improve and measure quality in health, public health and social care.
Resources and recommendations for adult and children’s social care, with example scenarios to help put them into practice.
Explore ways to plan, save money and make decisions on the best ways to use resources.
More ways we support you
Useful sources of information and advice for healthcare professionals, patients, parents and carers.
The British National Formulary (BNF) provides information about the selection, prescribing, dispensing and administration of drugs.
With over 370 topics to choose from, clinical knowledge summaries (CKS) can provide quick answers to clinical questions.
Our patient decision aids (PDAs) include treatment options available, likely outcomes, benefits, harms and uncertainties.
NICE conference 2026
Join us at this exceptional event, where senior managers, policymakers, commissioners, patients, frontline staff, and industry leaders unite in an inspiring and collaborative atmosphere.
